DIVIS LABORATORIES
|
The Current P/S Ratio of DIVIS LABORATORIES is 17.07.
Share Price | ₹5,836.5 | Feb 14,2025 |
Market Cap | ₹154,957.7 Cr | |
Sales-TTM | ₹9,078.0 Cr | TTM-Consolidated Results |
Price/Sales | 17.07x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹154,957.7 Cr] as on Feb 14,2025
(/) Sales [ ₹9,078.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 17.07x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '17.07 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES
PS Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 11.58x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 11.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2021 at 13.83x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.
How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
DIVIS LABORATORIES | 9,078.0 | 17.07 | 154,957.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.93 | 409,003.0 |
CIPLA LTD | 26,981.2 | 4.37 | 117,835.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.20 | 99,784.6 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.08 | 90,722.1 |
MANKIND PHARMA LTD | 11,641.0 | 8.49 | 98,888.9 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.02 | 101,923.0 |
LUPIN LTD | 22,001.6 | 4.08 | 89,860.6 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.12 | 65,619.0 |
ABBOTT INDIA LTD | 6,243.2 | 9.48 | 59,198.5 |
ALKEM LABORATORIES LTD | 12,756.6 | 4.36 | 55,643.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.12x |
Max industry PS | 17.07x |
Median industry PS | 4.37x |
Average industry PS | 6.75x |
You may also like the below Video Courses